metallothionein and diethyl-maleate

Metallothionein (MT) is a protein involved in heavy metal homeostasis and detoxification. According to several studies, MT could be involved in the antioxidant defense system, in which glutathione (GSH) is an essential component. The aim of this study was to verify the implication of MT in the antioxidant defense system in isolated rat hepatocytes. For this purpose, hepatocyte cultures were exposed to treatments known to modify MT or GSH levels. Zinc (Zn) was used as an inducer of MT while diethyl maleate (DEM) and buthionine sulfoximine (BSO) were used as GSH depletors. GSH, MT, and antioxidant enzyme activities were measured under conditions of MT induction and GSH depletion. Induction of MT synthesis through an 18-hour exposure to Zn (20 microM), did not result in any significant change in GSH levels or in activities of the antioxidant enzymes, glutathione-peroxidase (GSH-Px), catalase, and superoxide dismutase (SOD). DEM caused GSH depletion in cells, whether they were exposed to Zn or not, that lasted one h; after that time, GSH rose back to basal levels. BSO also caused GSH-depletion in cells exposed or unexposed to Zn, and no recovery in GSH levels was detectable during the entire period of exposure (12 h). However, GSH depletion induced by both DEM or BSO was attenuated in Zn-treated hepatocytes. Moreover, DEM and BSO exposures led to a depletion of MT levels in Zn-treated hepatocytes, indicating a link between GSH and MT metabolism. In cells unexposed to either Zn, DEM or BSO, there was an increase in GSH-Px and SOD activities after 6 and 12 h of incubation, respectively. Under the same conditions, catalase activity was inhibited after 6 h of incubation and returned to the activity found at t = 0 after 12 h of incubation. DEM and BSO treatments had no significant effect on GSH-Px or SOD activities although they led to inhibition of catalase activity. Taken together, our data indicate that MT induction, which creates a new pool of thiol groups in the cell cytosol, can attenuate GSH depletion induced by DEM or BSO. It appears that catalase is most sensitive to oxidative stress and that MT induction can antagonize the deleterious effects of such stress on the enzyme. This study supports the view that MT is part of the hepatocyte antioxidant-defense-system.

Topics: Animals; Antidotes; Antioxidants; Buthionine Sulfoximine; Catalase; Cell Survival; Glutathione; Glutathione Peroxidase; Liver; Maleates; Metallothionein; Proteins; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Time Factors; Zinc

A metallothionein-I-transgenic mouse strain (MT-TG) was characterized to determine whether they would be suitable to study the functions of this protein. MT-TG mice were visually indistinguishable from nontransgenic littermate controls, but had 10- to 20-fold higher basal levels of MT protein in pancreas, liver, and stomach, as well as 2- to 6-fold higher MT protein levels in other organs (kidney, intestine, uterus, testes, spleen, heart, and lung) than control mice, as determined by the Cd/hemoglobin assay. The MT-TG mice had 50% more Zn in liver and 300% more Zn in pancreas than control mice. Interestingly, female MT-TG mice have 4- to 5-fold higher MT levels in liver than those of males. To determine whether MT can be further increased by well-known MT inducers, control and MT-TG mice were given Zn (200 mumol/kg), Cd (20 mumol/kg), or diethyl maleate (DEM, 5 mmol/kg), and tissue MT concentrations were measured 24 hr later. MT-TG mice responded to MT inducers in a manner similar to control mice. The hepatic antioxidant components (glutathione (GSH), GSH-peroxidase, GSH-reductase, GSH S-transferase, superoxide dismutase, DT-diaphorase, and catalase) of MT-TG mice were not different from those of controls. The cytochrome P450 enzymes (total P450, b5, NADPH cytochrome c reductase) were normal in these MT-TG mice. The activities of CYP1A, CYP2B, and CYP2E enzymes in MT-TG mice were also similar to those of controls, as determined by ethoxy- and pentoxyresorufin O-dealkylation and chlorzoxazone 6-hydroxylation. Thus, MT-TG mice appear to be a good model for studying functions of MT.

Topics: Animals; Cadmium; Cytochrome P-450 Enzyme System; Digestive System; Female; Genitalia; Hemoglobins; Isoenzymes; Kidney; Liver; Lung; Male; Maleates; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Pancreas; Spleen; Tissue Distribution; Zinc

The effect of Glutathione (GSH) depletion on the induction of metallothionein (MT) synthesis by paraquat (PQ) was examined in ICR mice. An increase in hepatic MT level in mice was observed after a single PQ administration. Pretreatment of mice with L-buthionine-SR-sulfoximine (BSO), an inhibitor of GSH synthesis, enhanced the induction of hepatic and renal MT synthesis by PQ depending on the decreased tissue GSH level. A similar result was obtained by pretreatment with diethylmaleate, a GSH depleting agent. The ratio of hepatic MT-I to MT-II induced by PQ was not changed by BSO pretreatment. An increase in the hepatic MT level in GSH depleted mice was observed from 3 hr to 24 hr after PQ administration. An increase in the hepatic MT-I mRNA level after treatment with PQ was observed prior to hepatic MT induction in BSO pretreated mice. Pretreatment with actinomycin D, an inhibitor of mRNA synthesis, inhibits the PQ-induced increase in hepatic MT and MT-I mRNA levels in BSO pretreated mice. Pretreatment with BSO did not affect the induction of MT synthesis by zinc, cadmium or dexamethasone. Pretreatment with dexamethasone, an anti-inflammatory agent, enhanced the hepatic MT induction by PQ treatment in GSH depleted mice, while dexamethasone reduced the MT induction by turpentine oil, which is known to induce inflammation and hepatic MT synthesis. These findings suggest that GSH depletion enhances the induction of MT synthesis by PQ because of an increase in the transcription rate, and this enhancement of MT synthesis is not due to an inflammatory response caused by PQ.

Topics: Animals; Antimetabolites; Blotting, Northern; Buthionine Sulfoximine; Cadmium; Chlorides; Chromatography, Gel; Chromatography, Ion Exchange; Dactinomycin; Dexamethasone; Glucocorticoids; Glutathione; Herbicides; Kidney; Liver; Male; Maleates; Metallothionein; Mice; Mice, Inbred ICR; Paraquat; Protein Synthesis Inhibitors; Zinc Compounds

Male Sprague-Dawley rats (200-300 g) were pretreated (i.p.) with diethylmaleate (DEM; 3.1 mmol/kg) or propylene glycol (PG). After 1 h, three PG and three DEM groups received saline or sodium selenite (Se: 0.8 or 1.6 mg/kg) i.p. Eighty to one hundred percent mortality occurred within 3 h after Se in DEM-pretreated groups. Except for one PG and one DEM group, which were sacrificed after 1 h, the remaining groups received saline or Se (1.6 mg/kg) 25 h after pretreatment. No mortality occurred within 3 h after Se. Liver and kidney GSH decreased at 1 h, while liver MT increased at 28 h. The changes are related to Se-induced lethality.

Topics: Animals; Glutathione; Injections, Intraperitoneal; Kidney; Liver; Male; Maleates; Metallothionein; Propylene Glycol; Propylene Glycols; Rats; Rats, Sprague-Dawley; Selenium

Diethyl maleate (DEM) is a glutathione-depleting agent that can increase the levels of the sulfhydryl-rich protein metallothionein (MT) in liver. The purpose of the present study was to examine the mechanism(s) by which DEM increases mouse hepatic MT levels. DEM appears to be an indirect MT inducer as suggested by the lack of increase in MT levels when cultured mouse hepatocytes were exposed to DEM. Four possible mechanisms by which indirect MT inducers may cause an elevation in MT concentrations in liver were examined. Zn levels did not increase prior to the increase in hepatic MT, thus, a Zn redistribution to the liver is not the cause of the liver MT induction by DEM. The adrenal gland products were not required for MT induction in liver, as adrenalectomy did not abolish the increase in hepatic MT caused by DEM. The elevation in liver MT does not appear to be due solely to the decrease in liver glutathione (60%) in the initial hour after DEM, because phorone, which decreases liver glutathione (80%), produced only a fourfold increase in hepatic MT. Activation of macrophages does not seem to account for the rise in liver MT levels, as there was no increase in abundance of cytokine mRNAs for TNF-alpha, IL-1 beta, or IL-6 in the liver. These data suggest that the induction of hepatic MT by DEM does not occur in response to (1) an increase in liver Zn that precedes the increase in liver MT, (2) release of adrenal gland products, (3) decrease in liver glutathione, or (4) increased cytokine gene expression.

Topics: Adrenalectomy; Animals; Cytokines; Glutathione; Hormones; Liver; Male; Maleates; Metallothionein; Mice; Zinc

Metallothionein (MT) is a sulfhydryl-rich protein whose levels are increased by administration of a variety of agents including metals, cytokines, and oxidative stress agents. Recent studies have suggested that MT is involved in protecting against various forms of oxidative stress, but little is known about the induction of MT by oxidative stress agents. Diethyl maleate (DEM) causes oxidative stress by depleting glutathione levels and is quite effective at increasing hepatic concentrations of MT. The purpose of the current study was to learn more about the relationship between induction of MT and oxidative stress by characterizing this increase in hepatic MT levels produced by DEM. Administration of DEM (3 to 9 mmol/kg, sc) increased hepatic MT concentration in mice as much as 37-fold to 213 micrograms MT/g liver, which is similar to the hepatic MT level seen after administration of other effective MT inducers, such as Cd. The maximal increase of hepatic MT took place 12 to 24 hr after administration of 5 mmol DEM/kg. This rise in MT was preceded by a 60% depletion of hepatic glutathione 3 hr after DEM and increases in both MT-I and MT-II mRNA, which reached a peak 6 to 9 hr after DEM. Administration of DEM (3-5 mmol/kg, sc) also increased MT levels in Sprague-Dawley rats. Pretreatment with DEM protected against Cd-induced hepatotoxicity in a fashion which suggested that a functional MT was being synthesized. In summary, DEM is a highly effective inducer of MT which increases MT at the mRNA level.

Topics: Animals; Base Sequence; Blotting, Northern; Cadmium; Chemical and Drug Induced Liver Injury; Cytosol; Dose-Response Relationship, Drug; Glutathione; Immunoblotting; Liver; Liver Diseases; Male; Maleates; Metallothionein; Mice; Mice, Inbred Strains; Molecular Sequence Data; Rats; Rats, Inbred Strains; RNA, Messenger; Subcellular Fractions; Time Factors; Transcription, Genetic

Metallothionein (MT) is a low-molecular-weight protein with a high cysteine content that has been proposed to play a role in protecting against oxidative stress. For example, MT has been shown to be a scavenger of hydroxyl radicals in vitro, and cells with high levels of MT are resistant to radiation. However, it is not known if compounds that cause oxidative stress affect MT levels. Therefore, mice were injected subcutaneously with 11 chemicals (t-butyl hydroperoxide, paraquat, diquat, menadione, metronidazole, adriamycin, 3-methylindole, cisplatin, diamide, diethyl maleate, and phorone) that produce oxidative stress by four main mechanisms. MT was quantitated in the cytosol of major organs (liver, pancreas, spleen, kidney, intestine, heart, and lung) by the Cd/hemoglobin radioassay 24 hr after administration of the chemicals. All agents significantly increased MT levels in at least one organ. Liver was the most responsive to these agents in that all 11 chemicals increased MT concentrations in liver, with diethyl maleate, paraquat, and diamide producing 20- to 30-fold increases. Pancreas and kidney were the next most responsive organs to these chemicals. The organ least responsive to these agents was the heart, as only 3 compounds caused significant increases in MT concentrations in heart. Diethyl maleate and diquat were the most general inducers of MT in that they increased MT in six of the seven organs examined. No treatment resulted in a significant decrease in MT concentration in any organ. In conclusion, chemicals that produce oxidative stress by one of four distinct mechanisms are very effective at increasing MT concentrations in a variety of organs. This suggests that MT might be involved in protecting against oxidative stress.

Topics: Animals; Cisplatin; Cytosol; Diamide; Diquat; Doxorubicin; Ketones; Liver; Male; Maleates; Metallothionein; Metronidazole; Mice; Mice, Inbred Strains; Organ Specificity; Paraquat; Peroxides; Skatole; tert-Butylhydroperoxide; Vitamin K

Glutathione (GSH) depletion sensitizes human lung carcinoma (A549-T27) cells to the cytotoxic effects of Cd++. The effects of GSH depletion on Cd++ accumulation and Cd++-induced metallothionein (MT) content were investigated to determine the possible role of these Cd++ responses in the sensitization process. Cellular GSH was depleted to 20% to 25% of control levels with buthionine sulfoximine (BSO), or diethyl maleate (DEM), respectively. Neither treatment significantly affected Cd++-induced accumulation of exogenous 35s-cysteine into intracellular MT in a dose-dependent fashion. The results indicate that neither enhanced Cd++ accumulation nor reduced MT synthesis plays a primary role in affecting enhanced Cd++ cytotoxicity in A549 cells with reduced GSH levels. Although BSO inhibition of GSH synthesis enhanced MT synthesis, it sensitized the cells to Cd++, which suggests an additive effect of GSH and MT in cadmium cytoprotection. This observation also raises the possibility that intracellular cysteine levels limit Cd++-induced MT accumulation rates.

Topics: Buthionine Sulfoximine; Cadmium; Glutathione; Humans; Lung Neoplasms; Maleates; Metallothionein; Methionine Sulfoximine; Sulfur Radioisotopes; Tumor Cells, Cultured

The in vivo effect of cadmium (Cd) with or without prior administration of L-cysteine (Cys) or diethylmaleate (DEM) on hepatic and renal cytochrome c oxidase (Cyt-c-Ox), essential metals and mitochondrial thiols was investigated. Male Sprague-Dawley rats were given 25 micrograms Cd/kg (as Cd acetate) orally 5 times a week for 6 weeks. Different groups of animals additionally received either Cys (500 mg/kg per day, p.o.) or DEM (0.85 mg/kg, i.p.) by multiple administration. Parameters were determined 1 day after the last gavage. Cadmium decreased the activity of Cyt-c-Ox in mitochondria of livers but not in those of kidneys. Copper in both tissue and mitochondria were unaffected whereas hepatic tissue iron decreased by 50% upon Cd gavage. Cysteine pretreatment increased hepatic and especially renal mitochondrial Cd, but diminished the Cd effect on Cyt-c-Ox and increased hepatic tissue iron. Both DEM and DEM/Cd treatment decreased Cyt-c-Ox by 50% in liver but not in kidneys. Metallothionein was not significantly altered by either treatment. Considering data from all the experimental groups Cyt-c-Ox activity seems to be related rather to the amount of protein thiols than to either copper or iron in hepatic mitochondria. The data demonstrate the high susceptibility of hepatic vs. renal mitochondria and suggest the involvement of thiols in Cyt-c-Ox activity.

Topics: Animals; Cadmium; Cysteine; Electron Transport Complex IV; Iron; Male; Maleates; Metallothionein; Mitochondria; Rats; Rats, Inbred Strains

The effects of low-level cadmium (Cd) administration to rats on animal health, liver and kidney thiols, metallothionein, and glutathione reductase (GSSG reductase) and their modulation by cysteine (as a possible protector) and diethyl maleate (as a possible potentiator) have been investigated. Male Sprague-Dawley rats were treated with sodium or Cd acetate (25 micrograms Cd/kg) orally five times a week for 6 weeks. A second group of animals received cysteine (500 mg/kg; po) before each gavage while a third group received diethyl maleate (DEM) (0.85 mg/kg; ip) in addition to sodium or Cd acetate. When rats were treated with cadmium alone neither weight gain nor serum parameters indicative of hepato- or nephro-toxicity were affected. However, acid-soluble thiols, primarily glutathione, were decreased by about 25% in liver only. A tendency to a decrease in hepatic protein thiols was also noted. No changes were observed for hepatic or renal metallothionein in response to this low level of cadmium administration alone or in combination with the other treatments. Animals receiving cysteine, either alone or with cadmium, showed decreased body weight gain, but no change in serum parameters. Acid-soluble thiols in liver were lower in cysteine-treated rats (24%) and cysteine + Cd (33%) while kidney thiols were unaffected. Administration of DEM alone or with Cd did not cause any alteration in body weight gain. When given DEM + Cd, however, an increase in serum bilirubin was observed, which suggests interference with hepatobiliary function. Acid-soluble thiols were decreased by DEM alone (45%) and DEM + Cd (51%) in liver while renal thiols showed no change. Our data indicate that low-level Cd gavage decreases hepatic cellular thiols but not those of kidney. Cysteine gavage does not protect from the Cd-related effect. Indeed, cysteine itself was found to reduce acid-soluble thiols under the experimental conditions. This was observed only in liver, as was the decrease in thiols due to DEM treatment. DEM administration together with Cd resulted in signs of liver toxicity. There is no indication that inhibition of GSSG reductase by Cd might be involved in the thiol-decreasing effect of short-term repeated low-level gavage of Cd to rats.

Topics: Animals; Cadmium; Cysteine; Enteral Nutrition; Glutathione Reductase; Kidney; Liver; Male; Maleates; Metallothionein; Organ Size; Osmolar Concentration; Rats; Rats, Inbred Strains; Sulfhydryl Compounds

To investigate the mechanism by which zinc suppresses mercury toxicity, the effects of zinc and mercury on glutathione (GSH) metabolism in the rat kidney were studied. When the time course of GSH level in the rat kidney was examined at 2, 6, and 12 h after treatment of rats with both metals, an increase of GSH was found and was apparently related to the activation of some GSH-associated enzymes. In the kidney of rats treated with both metals, the response of the protective function involving GSH and GSH-associated enzymes depended on the magnitude of mercury toxicity but appeared to be independent of the zinc dosage. The administration of diethyl maleate (DEM), which depletes GSH, increased lipid peroxidation and mercury toxicity concomitantly with a decrease of GSH level in the kidney of rats treated with zinc and mercury. In conclusion, the data suggest that an increased GSH level in the kidney resulting from the activation of GSH-associated enzymes plays a role in the protective effect of zinc against mercury toxicity.

Topics: Animals; Glutamate-Cysteine Ligase; Glutathione; Glutathione Peroxidase; Kidney; Lipid Peroxides; Male; Maleates; Mercuric Chloride; Metallothionein; Rats; Rats, Inbred Strains; Time Factors; Zinc

The purpose of this study was to test if the tissue levels of glutathione and metallothioneins were inter-related. In rats, intraperitoneal administration of diethyl maleate or bromobenzene decreased glutathione levels in both the liver and kidney before doubling the metallothionein concentration in the liver and increasing that in kidneys by 40% starting from 6 h after intraperitoneal administration. Both Zn and Cd produced an increase in hepatic and renal metallothionein levels. However, unlike the responses to diethyl maleate and bromobenzene, the increase in metallothionein caused by the metals was not preceded by any significant changes in glutathione levels. Cd decreased the concentration of glutathione in the liver (at 36 h) and kidneys (at 24 h). In contrast, Zn produced an increase and no change in hepatic and renal glutathione concentrations, respectively. The conclusion is that tissue levels of metallothionein and glutathione are not always interrelated.

Topics: Animals; Bromobenzenes; Cadmium; Glutathione; Kidney; Liver; Male; Maleates; Metalloproteins; Metallothionein; Rats; Zinc